Crisaborole
CAS:906673-24-3
Purity: 99%
Molecular formula: C14H10BNO3
Molecular weight: 251.05
EINECS number: 250-635-4
![]()

1. Anti-inflammatory effect: Crisaborole inhibits the activity of PDE4 and reduces the release of inflammatory mediators, thereby reducing the inflammatory response of the skin and relieving itching, redness and other symptoms caused by eczema.
2. Moisturizing effect: Crisaborole has the effect of moisturizing the skin and helps improve the dryness and flaking of the skin of eczema patients.
3. Quickly relieve symptoms: Crisaborole can quickly relieve symptoms caused by eczema, such as itching, pain, redness and swelling, etc., and improve the patient's quality of life.
4. Long-term treatment: Crisaborole can be used as an option for long-term treatment of eczema, effectively controlling the onset and recurrence of symptoms.
![]()
Crisaborole is a phosphatase 4 (PDE4) inhibitor primarily used to treat mild to moderate forms of atopic dermatitis (eczema)



